Anna Sandebring

1.3k total citations
13 papers, 1.1k citations indexed

About

Anna Sandebring is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Anna Sandebring has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Anna Sandebring's work include Alzheimer's disease research and treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Anna Sandebring is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Anna Sandebring collaborates with scholars based in Sweden, United States and Spain. Anna Sandebring's co-authors include Ángel Cedazo-Mı́nguez, Mark Cookson, Kelly Jean Thomas Craig, Marcel van der Brug, Alexandra Beilina, David W. Miller, Bengt Winblad, Dragan Maric, Jeff Blackinton and Caroline Graff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Human Molecular Genetics.

In The Last Decade

Anna Sandebring

13 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Sandebring Sweden 9 699 429 407 296 288 13 1.1k
Marie Westerlund Sweden 19 676 1.0× 411 1.0× 563 1.4× 385 1.3× 125 0.4× 28 1.3k
Victor S. Van Laar United States 14 578 0.8× 216 0.5× 422 1.0× 296 1.0× 267 0.9× 18 1.0k
Sandra Gellhaar Sweden 10 465 0.7× 340 0.8× 317 0.8× 288 1.0× 86 0.3× 11 896
A. Kathrin Lutz Germany 6 878 1.3× 390 0.9× 821 2.0× 452 1.5× 481 1.7× 6 1.6k
Jason Schapansky Canada 11 345 0.5× 361 0.8× 377 0.9× 188 0.6× 169 0.6× 16 901
Suzanne J. Randle United Kingdom 14 639 0.9× 470 1.1× 245 0.6× 162 0.5× 242 0.8× 20 1.1k
Youngnam N. Jin United States 15 864 1.2× 325 0.8× 114 0.3× 317 1.1× 196 0.7× 29 1.2k
Aaron Daub United States 8 534 0.8× 396 0.9× 313 0.8× 296 1.0× 181 0.6× 9 1.0k
Matthias Höllerhage Germany 21 559 0.8× 440 1.0× 574 1.4× 331 1.1× 153 0.5× 42 1.4k
Jens Waak Germany 8 401 0.6× 223 0.5× 489 1.2× 270 0.9× 172 0.6× 8 982

Countries citing papers authored by Anna Sandebring

Since Specialization
Citations

This map shows the geographic impact of Anna Sandebring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sandebring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sandebring more than expected).

Fields of papers citing papers by Anna Sandebring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Sandebring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sandebring. The network helps show where Anna Sandebring may publish in the future.

Co-authorship network of co-authors of Anna Sandebring

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Sandebring. A scholar is included among the top collaborators of Anna Sandebring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Sandebring. Anna Sandebring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sandebring, Anna, Hedvig Welander, Bengt Winblad, Caroline Graff, & Lars O. Tjernberg. (2013). The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease. PLoS ONE. 8(2). e55847–e55847. 56 indexed citations
2.
Sandebring, Anna, Hedvig Welander, Bengt Winblad, Caroline Graff, & Lars O. Tjernberg. (2013). Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease. PLoS ONE. 8(5). 4 indexed citations
3.
Hedskog, Louise, Catarina Moreira Pinho, Riccardo Filadi, et al.. (2013). Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models. Proceedings of the National Academy of Sciences. 110(19). 7916–7921. 409 indexed citations
4.
Sandebring, Anna, Hedvig Welander, Bengt Winblad, Caroline Graff, & Lars O. Tjernberg. (2013). Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease. PLoS ONE. 8(5). 3 indexed citations
5.
Frykman, Susanne, Yasuhiro Teranishi, Ji‐Yeun Hur, et al.. (2012). Identification of two novel synaptic γ-secretase associated proteins that affect amyloid β-peptide levels without altering Notch processing. Neurochemistry International. 61(1). 108–118. 24 indexed citations
6.
Sandebring, Anna. (2012). Parkin- An E3 Ubiquitin Ligase with Multiple Substrates. Journal of Alzheimer’s Disease & Parkinsonism. 1(S10). 17 indexed citations
7.
Gil‐Bea, Francisco J., Susanne Akterin, Torbjörn Persson, et al.. (2012). Thioredoxin‐80 is a product of alpha‐secretase cleavage that inhibits amyloid‐beta aggregation and is decreased in Alzheimer's disease brain. EMBO Molecular Medicine. 4(10). 1097–1111. 40 indexed citations
8.
Craig, Kelly Jean Thomas, Melissa K. McCoy, Jeff Blackinton, et al.. (2010). DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Human Molecular Genetics. 20(1). 40–50. 371 indexed citations
9.
Sandebring, Anna, Kelly Jean Thomas Craig, Alexandra Beilina, et al.. (2009). Mitochondrial Alterations in PINK1 Deficient Cells Are Influenced by Calcineurin-Dependent Dephosphorylation of Dynamin-Related Protein 1. PLoS ONE. 4(5). e5701–e5701. 148 indexed citations
10.
Sandebring, Anna, Nodi Dehvari, Kelly Jean Thomas Craig, et al.. (2009). Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling. FEBS Journal. 276(18). 5041–5052. 43 indexed citations
11.
Dehvari, Nodi, Anna Sandebring, Amilcar Flores‐Morales, et al.. (2008). Parkin‐mediated ubiquitination regulates phospholipase C‐γ1. Journal of Cellular and Molecular Medicine. 13(9b). 3061–3068. 12 indexed citations
12.
Craig, Kelly Jean Thomas, Anna Sandebring, Alexandra Beilina, et al.. (2008). S9.4 Altered mitochondrial dynamics caused by loss of PTEN-induced kinase 1 function, associated with recessive parkinsonism, are reversed by downregulation of Dynamin-related protein 1. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1777. S55–S55. 1 indexed citations
13.
Akterin, Susanne, Anna Sandebring, Richard F. Cowburn, et al.. (2006). P3–383: Involvement of glutaredoxin–1 and thioredoxin–1 in beta–amyloid toxicity and Alzheimer's disease. Alzheimer s & Dementia. 2(3S_Part_16). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026